Your browser doesn't support javascript.
loading
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab.
Kijima, Toshiki; Yamamoto, Hina; Saito, Kazutaka; Kusuhara, Shota; Yoshida, Soichiro; Yokoyama, Minato; Matsuoka, Yoh; Numao, Noboru; Sakai, Yasuyuki; Matsubara, Nobuaki; Yuasa, Takeshi; Masuda, Hitoshi; Yonese, Junji; Kageyama, Yukio; Fujii, Yasuhisa.
Afiliação
  • Kijima T; Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Yamamoto H; Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Saito K; Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. kz-saito.uro@tmd.ac.jp.
  • Kusuhara S; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yoshida S; Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Yokoyama M; Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Matsuoka Y; Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Numao N; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Sakai Y; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Matsubara N; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yuasa T; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Masuda H; Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yonese J; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kageyama Y; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Fujii Y; Department of Urology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Cancer Immunol Immunother ; 70(3): 657-665, 2021 Mar.
Article em En | MEDLINE | ID: mdl-32876736
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Biomarcadores / Neoplasias Urológicas Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Biomarcadores / Neoplasias Urológicas Idioma: En Ano de publicação: 2021 Tipo de documento: Article